Literature DB >> 13129912

Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice.

Kazuhiko Takahashi1, Shinji Mizuarai, Hiromitsu Araki, Satoshi Mashiko, Akane Ishihara, Akio Kanatani, Hiraku Itadani, Hidehito Kotani.   

Abstract

Obesity is currently considered as an epidemic in the western world, and it represents a major risk factor for life-threatening diseases such as heart attack, stroke, diabetes, and cancer. Taking advantage of DNA microarray technology, we tried to identify the molecules explaining the relationship between obesity and vascular disorders, comparing mRNA expression of about 12,000 genes in white adipose tissue between normal, high fat diet-induced obesity (DIO) and d-Trp34 neuropeptide Y-induced obesity in mice. Expression of monocyte chemoattractant protein-1 (MCP-1) mRNA displayed a 7.2-fold increase in obese mice as compared with normal mice, leading to substantially elevated MCP-1 protein levels in adipocytes. MCP-1 levels in plasma were also increased in DIO mice, and a strong correlation between plasma MCP-1 levels and body weight was identified. We also showed that elevated MCP-1 protein levels in plasma increased the CD11b-positive monocyte/macrophage population in DIO mice. Furthermore, infusion of MCP-1 into lean mice increased the CD11b-positive monocyte population without inducing changes in body weight. Given the importance of MCP-1 in activation of monocytes and subsequent atherosclerotic development, these results suggest a novel role of adiposity in the development of vascular disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129912     DOI: 10.1074/jbc.M309895200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

1.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

2.  Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice.

Authors:  Nathalie Pamir; Timothy S McMillen; Kimberly A Edgel; Francis Kim; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

Review 3.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

4.  Monocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis.

Authors:  Miina K Ohman; Andrew P Wright; Kevin J Wickenheiser; Wei Luo; Hana M Russo; Daniel T Eitzman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

Review 5.  Regulation of stem cell differentiation in adipose tissue by chronic inflammation.

Authors:  Jianping Ye; Jeffery M Gimble
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-12       Impact factor: 2.557

6.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding.

Authors:  Stuart P Weisberg; Deborah Hunter; Reid Huber; Jacob Lemieux; Sarah Slaymaker; Kris Vaddi; Israel Charo; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

7.  Thrombin promotes diet-induced obesity through fibrin-driven inflammation.

Authors:  Anna K Kopec; Sara R Abrahams; Sherry Thornton; Joseph S Palumbo; Eric S Mullins; Senad Divanovic; Hartmut Weiler; A Phillip Owens; Nigel Mackman; Ashley Goss; Joanne van Ryn; James P Luyendyk; Matthew J Flick
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 8.  Adipose tissue inflammation in glucose metabolism.

Authors:  H L Kammoun; M J Kraakman; M A Febbraio
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

Review 9.  Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

Authors:  Jacquelyn J Maher; Pablo Leon; James C Ryan
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

Review 10.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance.

Authors:  J Ye
Journal:  Int J Obes (Lond)       Date:  2008-12-09       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.